Induced pluripotent stem cell technology in concert with high-throughput screening has created new opportunities for cardiac treatment development. Derived from adult cells and reprogrammed to an embryonic-like form, iPSCs provide an infinite supply of cardiomyocytes for disease modelling and medication testing. High-throughput screening helps to quickly evaluate many drug candidates, therefore...
Integration of iPSC Technology with High-Throughput Screening for Cardiac Therapies
I
